Bausch Health Companies (BHC) Restructuring Costs (2009 - 2026)
Bausch Health Companies (BHC) reported Restructuring Costs of $13.0 million for Q1 2026, up 1200.0% on a YoY basis from $1.0 million in Q1 2025, and down 53.57% sequentially from $28.0 million in Q4 2025.
Bausch Health Companies (BHC) Restructuring Costs (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Restructuring Costs data on file, last reported at $13.0 million in Q1 2026.
- For the quarter ending Q1 2026, Restructuring Costs rose 1200.0% year-over-year to $13.0 million; the trailing twelve-month figure through Mar 2026 stood at $89.0 million (up 323.81% YoY), and the FY2025 full-year result was $77.0 million, up 140.62% from the prior year.
- Restructuring Costs declined to $13.0 million in Q1 2026, from $28.0 million in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $35.0 million in Q2 2022 to a low of $1.0 million in Q3 2024.
- A 5-year average of $14.5 million and a median of $13.0 million in 2022 frame the typical range for Restructuring Costs.
- Across the five-year window, Restructuring Costs sank 92.86% in 2024 and jumped 1600.0% in 2025, its largest moves.
- Tracing BHC's Restructuring Costs over 5 years: stood at $5.0 million in 2022, then soared by 340.0% to $22.0 million in 2023, then tumbled by 68.18% to $7.0 million in 2024, then jumped by 300.0% to $28.0 million in 2025, then sank by 53.57% to $13.0 million in 2026.
- Business Quant data shows BHC's Restructuring Costs at $13.0 million in Q1 2026, $28.0 million in Q4 2025, and $17.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.00 Mn |
| Dec 31, 2025 | 28.00 Mn |
| Sep 30, 2025 | 17.00 Mn |
| Jun 30, 2025 | 31.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 7.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 12.00 Mn |
| Mar 31, 2024 | 12.00 Mn |
| Dec 31, 2023 | 22.00 Mn |
| Sep 30, 2023 | 14.00 Mn |
| Jun 30, 2023 | 16.00 Mn |
| Mar 31, 2023 | 10.00 Mn |
| Dec 31, 2022 | 5.00 Mn |
| Sep 30, 2022 | 10.00 Mn |
| Jun 30, 2022 | 35.00 Mn |
| Mar 31, 2022 | 13.00 Mn |
| Dec 31, 2021 | 21.00 Mn |
| Sep 30, 2021 | 8.00 Mn |
| Jun 30, 2021 | 9.00 Mn |